Garen G. Bohlin - 11 May 2026 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Reporting relationship: Director
Issuer ticker: COLL
Reported as of: 11 May 2026
Net transaction value: -$323,491
SEC form: 4
Accepted by SEC: 13 May 2026, 16:05:05 UTC
Prior SEC filing: 29 May 2025
Next SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Colleen Tupper as Attorney-in-Fact for Garen G. Bohlin

Key filing fact

Garen G. Bohlin filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 13 May 2026.

Key facts

This page summarizes Garen G. Bohlin's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 May 2026, 16:05.

Change

Previous filing in this sequence was filed on 29 May 2025.
Current net transaction value: -$323,491.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001254705 Primary reporting owner

BOHLIN GAREN G

Relationship: Director
Address: C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON
Signature: /s/ Colleen Tupper as Attorney-in-Fact for Garen G. Bohlin
Signature date: 13 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COLL transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,700
Change %: +14%
Price: $16.49^*
Shares after: 70,959
Date: 11 May 2026
Ownership: Direct

COLL transaction

Common Stock

Sale

Transaction value: $323,491
Shares: -8,700
Change %: -12%
Price: $37.18
Shares after: 62,259
Date: 11 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

COLL transaction Derivative

Stock Option (Right to Purchase)

Options Exercise

Transaction value
Shares: -8,700
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,700
Exercise price: $16.49
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The option is fully vested and exercisable.